Guidance and clarification from NHS England and NHS Improvement on the use of Personal Protective Equipment, NHS Home delivery services, operational support and service management to minimise risk of COVID-19 spread- as well as signposting to guidance on workforce issues relating to pre-registration trainee pharmacists and pharmacy technicians. Link.
An article in Medscape highlights how American cardiology associations have urged caution when prescribing hydroxychloroquine and azithromycin for COVID-19 in patients with cardiovascular disease. Link.
An article Diabetes.co.uk has highlighted the potential dangers of combining hydroxychloroquine and chloroquine with metfromin in COVID-19 patients who suffer from co-morbid diabetes mellitus. Link.
Liverpool University has formulated an online resource which enables users to see up-to-date information relating to drug interactions with experimental COVID-19 therapies. Link.
European Medicines Agency
The European Medicines Agency has reported that EU authorities have agreed new measures to support the availability of medicines used in the COVID-19 pandemic. It outlines a number of measures to counter medicine shortages due to supply disruptions. Link.
Royal Pharmaceutical Society
The Royal Pharmaceutical Society has a range of the latest resources available on its website. Link. The Royal Pharmaceutical Society has provided advice on the roles and activities volunteers, students and returning pharmacists can play in order to increase capacity within the pharmacy sector. Link. A series of webinars from a number of professionals in the pharmacy sector. They are available on the Royal Pharmaceutical Society website. Link.
General Pharmaceutical Council
The General Pharmaceutical Council has provided on its website a list of the latest resources relating to COVID-19 and pharmacy. Link.
Royal Pharmaceutical Society & General Pharmaceutical Council
The Royal Pharmaceutical Society and the General Pharmaceutical Council have released a joint statement on the role volunteers have to play in delivering medicines. Link.
Medicines and Healthcare Products Regulatory Agency (MHPRA) & Commission of Human Medicines (CHM) Expert Working Group
The MHRA and CHM Expert Working Group have concluded that there’s currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms. Link.
Commission of Human Medicines (CHM) Working Group
Advice from the Commission on Human Medicines on ibuprofen use in COVID-19. Link.
Specialist Pharmacy Service
COVID-19 Medicines Guidance Summaries provided by the Specialist Pharmacy Service. Link. A “Medicines Safety COVID-19” poster/screensaver for all clinical areas, provided by the Specialist Pharmacy Service and addressing the issue of changes in drug packaging (due to procurement from different manufacturers to avoid shortages). Link.
Health Education England
Health Education England have issued joint guidance on accommodating pharmacy undergraduate students to support the pharmacy workforce. Link.
National Pharmacy Association
The National Pharmacy Association has provided up-to-date resources, guidance and webinars on its website. Link.
The Pharmaceutical Services Negotiating Committee
The Pharmaceutical Services Negotiating Committee has provided a list of resources and updates relating to COVID-19- including a video message from the National Pharmacy Bodies. Link.
International Pharmaceutical Federation
A COVID-19 Information hub on the International Pharmaceutical Federation website. Link.
Centre for Postgraduate Pharmacy Education
The Centre for Postgraduate Pharmacy Education has provided a guide to returning to pharmacy to support those specifically returning to hospital practice, including an updated self-assessment framework. Link.